X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Therapeutic Advances in Neurological Disorders

期刊標題檢索 THER ADV NEUROL 最新評論: It has been 12 days since submission, with only an ADM added in the ... (2025-07-01)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Therapeutic Advances in Neurological Disorders]您好,您是該頁面的第 19416 位訪客。

期刊簡介
期刊名稱Therapeutic Advances in Neurological Disorders Therapeutic Advances in Neurological Disorders
LetPub Score
7.3
50 ratings
Rate

Reputation
8.3

Influence
6.2

Speed
8.8

期刊簡稱THER ADV NEUROL DISO
ISSN1756-2856
E-ISSN1756-2864
h-index40
CiteScore
CiteScoreSJRSNIPCiteScore Rank
8.501.6141.576
Subject fieldQuartilesRankPercentile
Category: Neuroscience
Subcategory: Neurology
Q126 / 194
Category: Neuroscience
Subcategory: Neurology (clinical)
Q155 / 400
Category: Neuroscience
Subcategory: Pharmacology
Q152 / 321

自引率 (2023-2024)2.10%自引率趨勢
掲載範囲
Therapeutic Advances in Neurological Disorders delivers the highest quality peer-reviewed original research articles, reviews, and scholarly comment on pioneering efforts and innovative studies in the medical treatment of neurological conditions. The journal has a strong clinical and pharmacological focus and is aimed at an international audience of clinicians and researchers in neurology and related disciplines, providing an online forum for rapid dissemination of recent research and perspectives in this area.

The editors welcome original research articles across all areas of neurology.

The journal is dedicated to publishing clinical research. We do not publish preclinical research, including basic laboratory research and animal studies.

Review articles include expert opinion/perspective reviews (including single-drug and drug class reviews), narrative reviews and therapeutic area reviews. Systematic reviews, meta-analyses, postmarketing and health economic and pharmacoeconomic reviews are also welcomed. The appropriate EQUATOR Network reporting guidelines should be followed (e.g. CONSORT for randomized, controlled trials and PRISMA for systematic reviews/meta-analyses). The journal endorses the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first patient enrolment. The trial registry name and URL, and registration number must be included at the end of the abstract.

The journal adheres to a single-blind review process in which the reviewer’s name is routinely withheld from the author unless the reviewer requests a preference for their identity to be revealed. Manuscripts are reviewed by at least two referees.
官方網站https://journals.sagepub.com/home/tan
在線稿件提交https://mc.manuscriptcentral.com/tand
開放訪問Yes
出版商SAGE Publications Inc.
主題領域CLINICAL NEUROLOGY
出版國/地區ENGLAND
發行頻率継続刊行
創刊年2008
每年文章數96每年文章數趨勢
黃金OA百分比94.25%
OA Related Info
APC: Yes( USD2650; )
APC waiver:Check Notes
Other charges: No
Keywords: neurological disorders、neurology
Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
CLINICAL NEUROLOGYSCIEQ150/285
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1756-2856%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: 15 Weeks
競爭力 *來自作者的數據:
參考鏈接
相關期刊 【Therapeutic Advances in Neurological Disorders】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    CA-A CANCER JOURNAL FOR CLINICIANSH-index: 144

    CiteScore: 1154.20
    NATURE REVIEWS DRUG DISCOVERYH-index: 289

    CiteScore: 181.80
    LANCETH-index: 700

    CiteScore: 87.60
    NEW ENGLAND JOURNAL OF MEDICINEH-index: 933

    CiteScore: 96.40
    Nature Reviews Clinical OncologyH-index: 127

    CiteScore: 114.50
    Nature Reviews Disease PrimersH-index: 48

    CiteScore: 113.30
    NATURE REVIEWS CANCERH-index: 396

    CiteScore: 103.80
    MMWR Recommendations and ReportsH-index: 0

    CiteScore: 129.90
    NATURE REVIEWS IMMUNOLOGYH-index: 351

    CiteScore: 84.70
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATIONH-index: 622

    CiteScore: 30.80
    學科內最受檢索的期刊 頁面查看次數
    PHARMACEUTICAL BIOLOGY12063035
    Frontiers in Pharmacology6461981
    BIOMATERIALS1500425
    Cancer Medicine976749
    Oncogenesis944150
    MEDICINE683152
    JOURNAL OF ETHNOPHARMACOLOGY680333
    Archives of Medical Science677914
    Oncology Letters583351
    Frontiers in Immunology531994
  •  

    Therapeutic Advances in Neurological Disorders Therapeutic Advances in Neurological Disorders
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    下一頁    末頁  (頁
/2)
  [Therapeutic Advances in Neurological Disorders] 的評論撰寫評論
作者: yuangaodi


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-07-01 20:23:14 評論於
It has been 12 days since submission, with only an ADM added in the middle but the status has remained as "Submitted". How long does it usually take for the first decision to be made? Will there be a "With editor" status, or will it go straight to review?
(0) 讚! | yuangaodi

作者: Lydie


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-24 16:54:23 評論於
Has the status changed?
(0) 讚! | Lydie

作者: Lihua W


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-16 09:37:38 評論於
Just submitted for a week.
(0) 讚! | Lihua W

作者: 犹望一稔


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-15 10:42:05 評論於
How long does it usually take for something to be under review? Is there a high chance of it being rejected after being sent for external review?
(1) 讚! | 犹望一稔

作者: 云之上


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-13 08:56:54 評論於
Hello, I would like to ask how long the "submitted" status lasts after you submit it.
(0) 讚! | 云之上

作者: 云之上


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-13 08:55:31 評論於
After submission, it has been in the "submitted" status the whole time... How long do I have to wait?
(0) 讚! | 云之上

作者: 犬走今雨


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-27 20:54:42 評論於
How much is the fee?
(0) 讚! | 犬走今雨

作者: 筑阳绮艳


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-03 17:21:31 評論於
Review speed: 2.0 | Submission acceptance rate: 95.0
Experience sharing: I submitted an article, and the first review took about a month, which provided some feedback and suggestions. The second review also took around a month, but overall it went quite smoothly
(0) 讚! | 筑阳绮艳

作者: Michelle Doris


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-02 22:56:55 評論於
Review Speed: 3.0 | Acceptance Rate: 75.0 Experience Sharing: I heard from my senior sister that this journal is quite recognized by peers. I checked the high-quality medical journals in the 2nd area of the Chinese Academy of Sciences, and the self-citation rate has always been very low at 3.7%. I will pay special attention to it
(0) 讚! | Michelle Doris

作者: 上清雨真


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-28 19:48:46 評論於
This journal has a high impact in the field of neuroscience, and I think it is well-deserved to be included in the JCR Q1 journal list
(0) 讚! | 上清雨真

作者: Darlene Pepys


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-28 09:17:47 評論於
Submission publication time: Generally, one month for the first review, one month for the second review, with a total duration of 2-3 months for acceptance
(0) 讚! | Darlene Pepys

作者: 风陵松月


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-05 20:23:48 評論於
Review speed: 2.0 | Submission success rate: 50.0
Emphasized research direction: neurology
Experience sharing: relatively friendly to Chinese researchers. The professionalism of the journal editors is quite high. Four reviewers provided 2 rounds of reviews consecutively, and their comments were quite professional. The journal's processing speed is average, taking nearly half a year from submission to acceptance
(0) 讚! | 风陵松月

作者: 韦陀丽萍


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-08-25 13:23:51 評論於
Hasn't it been sent for external review for so long?
(0) 讚! | 韦陀丽萍

作者: 龙鳞代梅


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-07-23 15:08:20 評論於
It's been almost 2 months since my article was submitted. I'm starting to wonder if I should withdraw it
(0) 讚! | 龙鳞代梅

作者: 宗室哲圣


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-04-05 14:52:16 評論於
Oh my goodness, it's been over a month and still no progress on sending it out for review. No response even after reminders
(0) 讚! | 宗室哲圣

作者: 东风昆纶


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-05-27 20:38:57 評論於
I F expected 6
(0) 讚! | 东风昆纶

作者: 东风昆纶


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-05-15 11:13:53 評論於
Review speed: 3.0 | Submission hit rate: 75.0 Experience sharing: What is the forecast for 2022?
(0) 讚! | 东风昆纶

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 21:36:25 評論於
Revised, that is, modified reply. In the submission and publication of papers in SCI journals, it is a step to make appropriate modifications in response to editor's letter and to explain the modified content in detail in the reply letter to the editor, requesting a re-review of the manuscript
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 21:29:57 評論於
Revised, i.e. the modified reply. We need to provide detailed responses to the modifications suggested by the reviewer
(0) 讚! | 维尔娜菲茨杰拉德

作者: Darlene Pepys


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 14:56:52 評論於
What does recuperation involve?
(0) 讚! | Darlene Pepys

作者: 北国博达


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-26 16:09:42 評論於
What is meant by recycling?
(0) 讚! | 北国博达

作者: 珉林高峰


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-13 11:54:38 評論於
This weight loss program involves a combination of healthy eating and regular exercise
(0) 讚! | 珉林高峰

作者: 龙鳞孝礼


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-11-19 13:40:42 評論於
Experience Sharing: The reason why this journal is good is that it has a dedicated executive editor who can make many decisions and speed up the review process. Many journals require the opinions of 2-3 reviewers to be unified, so the editor can quickly come to a conclusion. However, if the opinions are not unified and the editor cannot make a decision, it may be necessary to find another reviewer for arbitration, which will prolong the review process. This is one of the reasons why many people have excessively long review times
(0) 讚! | 龙鳞孝礼

作者: 龙鳞孝礼


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-11-18 16:10:47 評論於
The strength of high-quality journals lies in their professional and efficient peer review process! During the submission period, I communicated multiple times with the editorial board members, and I feel that the editorial board of this journal is very high in level and efficiency. I truly commend them!
(0) 讚! | 龙鳞孝礼

作者: 修然小公主


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-11-13 15:46:38 評論於
I saw that some experts who have submitted manuscripts said that this journal has an exclusive handling editor. Does it mean the review process will be much faster than other journals?
(0) 讚! | 修然小公主

首頁    上一頁    1    2    下一頁    末頁  (頁
/2)

開始撰寫 [Therapeutic Advances in Neurological Disorders] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*